# A Study of the Safety and Efficacy of DFD-03 Lotion in the Treatment of Acne Vulgaris for 12 Weeks

> **NCT03292640** · PHASE3 · COMPLETED · sponsor: **Dr. Reddy's Laboratories Limited** · enrollment: 547 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** DFD-03 (0.1% tazarotene) Lotion
- **DRUG:** DFD-03 (0% tazarotene) Lotion (Placebo)

## Key facts

- **NCT ID:** NCT03292640
- **Lead sponsor:** Dr. Reddy's Laboratories Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-06
- **Primary completion:** 2018-05-14
- **Final completion:** 2018-05-14
- **Target enrollment:** 547 (ACTUAL)
- **Last updated:** 2021-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03292640

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03292640, "A Study of the Safety and Efficacy of DFD-03 Lotion in the Treatment of Acne Vulgaris for 12 Weeks". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03292640. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*